Palivizumab Biosimilar, Anti-RSV Monoclonal Antibody

The cheapest research grade palivizumab biosimilar (anti-human respiratory syncytial virus (RSV) monoclonal antibody, mAb) for ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in vivo assays for studying biological pathways affected by palivizumab. The research grade palivizumab biosimilar protein is for research use only.

Synonyms: respiratory syncytial virus, RSV